Bhagiradha Chemicals reports Q1 FY27 EBITDA of Rs 30.5 crore

Bhagiradha Chemicals & Industries Limited reported EBITDA of Rs 30.5 crore for Q1 FY27, up 240% year on year from Rs 9.0 crore, while revenue from operations was Rs 195.0 crore. The quarterly presentation also showed EBITDA margin expanding to 15.7% from 7.3% a year earlier.

What did Bhagiradha Chemicals report for Q1 FY27?

Bhagiradha Chemicals reported revenue from operations of Rs 195.0 crore and EBITDA of Rs 30.5 crore for the quarter ended June 30, 2026. The financial highlights were disclosed in the company’s Q1 FY27 investor presentation, which was reported to the exchange on August 6, 2026 under Regulation 30 of the Listing Obligations and Disclosure Requirements regulations.

The EBITDA result was Rs 21.5 crore higher than the Rs 9.0 crore reported in Q1 FY26. This represented year-on-year growth of 240%. EBITDA margin rose by 839 basis points to 15.7%, compared with 7.3% in the corresponding quarter of the previous financial year. The supplied presentation information does not provide quarterly profit after tax, volume data, segment-wise revenue, or management guidance.

How did the Q1 FY27 margin performance change?

Bhagiradha Chemicals improved its Q1 FY27 EBITDA margin to 15.7%, an increase of 839 basis points from 7.3% in Q1 FY26. The expansion in margin accompanied the increase in EBITDA from Rs 9.0 crore to Rs 30.5 crore over the year-earlier period.

EBITDA is a measure of operating earnings before interest, tax, depreciation and amortisation. In this case, the disclosed figures show that operating profitability increased faster than the reported revenue figure alone can explain without further cost data. The investor presentation information provided does not break down changes in raw-material costs, product pricing, capacity utilisation, finance costs, or other operating expenses. Therefore, the reported numbers establish the margin change but do not specify its individual drivers.

What business does Bhagiradha Chemicals operate?

Bhagiradha Chemicals manufactures crop-protection chemicals for customers in India, other Asian markets and Europe. Its stated customer base includes agrochemical manufacturers, pesticide formulators and traders, placing the company in the pesticides and agrochemicals industry.

The company’s portfolio includes insecticides, fungicides, herbicides and specialty intermediates. Products listed in the supplied material include chlorpyrifos-based technical products, clodinafop-propargyl, triclopyr, azoxystrobin and trifloxystrobin. Bhagiradha Chemicals has also stated that it operates research and development facilities within its factory premises to develop processes for generic products and improve efficiency in existing operations.

What is the company’s manufacturing and financial background?

Bhagiradha Chemicals was incorporated on July 7, 1993, and is headquartered in Hyderabad. Its manufacturing facility is located in Ongole in Andhra Pradesh’s Prakasam district. The company had set up a plant at Cheruvukommupalem to manufacture 300 tonnes a year of pesticides including technical-grade chlorpyrifos; that project was financed through a public issue in 1996 and commissioned in the same year.

The presentation also referred to the conversion of loans worth Rs 367.52 crore into equity in a subsidiary as of May 2025. It stated that the debt-to-equity ratio had remained low, fluctuating around 0.1 to 0.4 between FY21 and FY26. These disclosures provide context on the company’s capital structure, although the supplied material does not provide a debt-to-equity figure for Q1 FY27.

How does the quarterly update matter for investors and the agrochemical sector?

The Q1 FY27 disclosure matters because it records a significant improvement in Bhagiradha Chemicals’ operating earnings and margin compared with Q1 FY26. Revenue from operations of Rs 195.0 crore and EBITDA of Rs 30.5 crore are the primary reported measures for assessing the quarter, especially as no earnings-call transcript was published for this period.

For investors, the absence of a transcript means the available information is limited to the investor presentation and should not be treated as management guidance. The supplied data does not include a share-price reaction, order book, export split, production volumes or outlook. For the wider agrochemical industry, the update reflects the operating performance of one manufacturer serving formulators, traders and agrochemical companies, but it does not establish a broader sector trend on its own.

Conclusion

Bhagiradha Chemicals delivered Q1 FY27 EBITDA of Rs 30.5 crore, up 240% year on year, alongside an EBITDA margin of 15.7%. The result compared with Rs 9.0 crore of EBITDA and a 7.3% margin in Q1 FY26, while reported revenue from operations stood at Rs 195.0 crore.

The next disclosed reference point is the company’s subsequent quarterly financial communication and investor presentation. Investors will be able to assess whether the higher operating margin is sustained when Bhagiradha Chemicals provides further results, along with any additional disclosure on revenue mix, costs, debt and subsidiary-related capital structure.